阿拉赛珠单抗
Alacizumab (Anti-VEGFR2 / KDR / CD309)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$820.00
Member price
Product Availability
3-5days
Price
$2300.00
Member price
Product Availability
3-5days
Price
$4200.00
Member price
Product Availability
3-5days
Price
$19500.00
Member price
Product Availability
3-5days
Price
$34000.00
Member price
Quantity
- +
Product Overview
Product Name Alacizumab (Anti-VEGFR2 / KDR / CD309)
CAS934216-54-3
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Security information
Product details

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.

Related literature
Related
Sorry, no related items
History
Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)
Alacizumab (Anti-VEGFR2 / KDR / CD309)
Anti-Human CD4 Monoclonal Antibody(Ibalizumab)
Brontictuzumab (Anti-NOTCH1)
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7)
Siplizumab (Synonyms: MEDI-507)
Ranibizumab (Anti-VEGFA)
Abatacept (Synonyms: CTLA4lg; BMS-188667)
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)